Recent research suggests that Sacubitril/Valsartan may enhance treatment outcomes for diabetic cardiomyopathy by modulating the immune response to inflammation. Diabetic cardiomyopathy is a condition characterized by structural and functional changes in the heart muscle due to diabetes. The study explores how the combination of Sacubitril and Valsartan influences the immune system’s response to inflammation, potentially […]
Category: immunomodulation
Peanut Oral Immunotherapy Boosts Relief in Adults
Peanut oral immunotherapy shows promising results in adults, with significant increases in the highest tolerated dose. A study involving 18 patients demonstrated that 78% tolerated at least 1.4 g of peanut protein, while 67% of the intention-to-treat population met the primary endpoint. The median highest tolerated dose surged from 30 mg to 3000 mg, a […]
